Semaglutide Recall: CGMP Deviations Reported

This alert was compiled from official government recall data published by the FDA using automated analysis. All facts are sourced directly from official records. Last verified April 6, 2026.

You just received a prescription from your doctor. You drop it off at your local compounding pharmacy, trusting they’ll provide you with the medication you need. What you *don't* expect is that the raw ingredients used to make your medication might be compromised. In 2026, American shoppers need to be aware of a significant product recall in the United States involving Semaglutide, a medication often prescribed for weight management and diabetes. This recall doesn't affect pre-filled pens you might get directly from a major pharmacy chain, but rather, it concerns Semaglutide intended *only* for prescription compounding.

Harbin Jixianglong Biotech Co., Ltd. Semaglutide Recall: What You Need to Know

This recall involves Semaglutide manufactured by Harbin Jixianglong Biotech Co., Ltd., a company located in Harbin, China. The product is packaged in various sizes: 1g (NDC 84385-106-01), 5g (NDC 84385-106-02), 10g (NDC 84385-106-06), 25g (NDC 84385-106-03), 50g (NDC 84385-106-04), and 100g (NDC 84385-106-05). The Semaglutide in question is intended *only* for use in prescription compounding. That means it's *not* the pre-filled injectable pens you'd get from a standard pharmacy like CVS, Walgreens, or even the pharmacy section at Walmart or Costco. This recall impacts compounding pharmacies that source their raw materials from this specific manufacturer. The affected batch number is CP-030-20250911, with a manufacture date of September 25th, 2025, and a retest date of September 24th, 2027. The recall was announced on March 11th, 2026, so it's a relatively recent development. The distribution of this potentially affected Semaglutide was nationwide within the United States, so it could potentially affect people anywhere from California to Florida, and everywhere in between.

Why Was This Semaglutide Recalled?

The reason for this product recall in the United States is due to CGMP (Current Good Manufacturing Practice) deviations. Specifically, Harbin Jixianglong Biotech Co., Ltd. failed to complete process validation and bacterial endotoxin method validation before distributing the Semaglutide. In simpler terms, the company didn’t properly verify that their manufacturing processes consistently produced a safe and effective product, and they didn't adequately test for bacterial contamination. Failing to validate these critical steps can lead to serious health risks. This is classified as a Class II recall. The agency confirmed that, according to the FDA, a Class II recall means that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Potential Risks for U.S. Consumers

Nobody wants to find out their medication is potentially dangerous. If a compounding pharmacy used this recalled Semaglutide, the resulting medication could be contaminated or less effective than intended. Contamination could lead to infections, allergic reactions, or other adverse health effects. Sub-potency could mean your condition isn't being properly treated. While the FDA hasn't specified the exact type or level of contamination, the lack of proper bacterial endotoxin testing is a major concern. Endotoxins are toxins released by bacteria, and exposure to high levels can cause fever, inflammation, and even shock. It's always best to err on the side of caution when it comes to your health.

What You Should Do Right Now

If you are currently taking Semaglutide from a compounding pharmacy, here’s what you need to do to protect your health:

1. Contact the compounding pharmacy that dispensed your Semaglutide prescription immediately and ask if they used Semaglutide from Harbin Jixianglong Biotech Co., Ltd., batch number CP-030-20250911.
2. If your pharmacy confirms they used the recalled Semaglutide, stop using the medication immediately and do *not* administer another dose.
3. Contact your healthcare provider to discuss alternative treatment options and to report any adverse effects you may have experienced while taking the medication. Tell them it's Semaglutide, batch # CP-030-20250911, from Harbin Jixianglong Biotech Co., Ltd.
4. Work with your healthcare provider to determine the best course of action, which may include blood tests or other evaluations to assess any potential health impacts.

Understanding the Context of FDA Recalls

It's worth understanding that recalls are not uncommon. The FDA regularly issues recalls for a variety of products, from food and beverages to medical devices and medications. While the exact number fluctuates, the FDA issues hundreds of recalls each year. This Semaglutide recall highlights the importance of robust quality control measures in the pharmaceutical industry. Even though Harbin Jixianglong Biotech Co., Ltd. is based in China, their products are sold across the U.S., emphasizing the global nature of supply chains and the need for international oversight. This recall serves as a reminder to all of us to be proactive about our health and to stay informed about potential risks associated with the products we use. Don't hesitate to ask your pharmacist or doctor questions about the medications you are taking. This recall was announced by the U.S. Food and Drug Administration (FDA). For the official notice and complete details, visit www.fda.gov.

Frequently Asked Questions

Q: What is Semaglutide?

Semaglutide is a medication used to treat type 2 diabetes and, in some cases, for weight management; it helps regulate blood sugar and can reduce appetite.

Q: How do I know if I received the recalled Semaglutide?

Contact the compounding pharmacy that dispensed your prescription and ask them directly if they used Semaglutide from Harbin Jixianglong Biotech Co., Ltd., batch number CP-030-20250911.

Q: What are the symptoms of bacterial endotoxin contamination?

Symptoms can include fever, chills, inflammation, and in severe cases, shock; contact your doctor immediately if you experience any of these symptoms after taking Semaglutide from a compounding pharmacy.

Q: Can I get a refund for my Semaglutide prescription?

Contact the compounding pharmacy that dispensed the medication to inquire about their refund policy for recalled products; your insurance provider may also offer guidance.

Q: Where can I find more information about this recall?

The official source of information is the U.S. Food and Drug Administration (FDA) website (www.fda.gov); search for "Harbin Jixianglong Biotech Semaglutide recall" to find the specific announcement.